The Price is Right? Promoting Local Production for ARVs in Sub-Saharan Africa
(2008; 4 pages)


Affordability is a key concern of European donors who finance antiretroviral drugs (ARVs) to treat AIDS in Sub-Saharan African countries. In country manufacture of ARV drugs could favourably affect ARV access through increased affordability; however, generics are a volume based market, relying on economies of scale. The ability of Sub-Saharan African countries to reduce their prices below large-scale manufacturers in India is challenging. Additionally, these medicines must meet WHO prequalification standards. While the cost of second-line ARVs remains a concern, donors should focus resources on other components ARV access, such as the supply of human resources for health, health infrastructure and issues of sustainable financing.

Le Portail d'information - Médicaments essentiels et produits de santé a été conçu et est maintenu par l'ONG Human Info. Dernière mise à jour: le 4 juillet 2016